scholarly article | Q13442814 |
meta-analysis | Q815382 |
review article | Q7318358 |
P50 | author | Marleen Temmerman | Q340097 |
Matthias Egger | Q19996372 | ||
Nicola Low | Q28152053 | ||
Matthew F Chersich | Q56440902 | ||
Janneke van de Wijgert | Q60433577 | ||
Landon Myer | Q60557491 | ||
Rupert Kaul | Q63355154 | ||
Jared M Baeten | Q89443633 | ||
Ariane van der Straten | Q91106590 | ||
Sinead Delany-Moretlwe | Q42572161 | ||
Kurt Schmidlin | Q48567683 | ||
Marcel Zwahlen | Q55136094 | ||
Suzanna C Francis | Q37841402 | ||
Richard J. Hayes | Q38640707 | ||
Nuala McGrath | Q42430120 | ||
P2093 | author name string | Deborah Watson-Jones | |
Joelle Brown | |||
Charles Morrison | |||
Adriane Martin Hilber | |||
P2860 | cites work | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q21092368 |
Modeling and variable selection in epidemiologic analysis | Q24538916 | ||
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women | Q24629582 | ||
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation | Q24645157 | ||
Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics | Q24671567 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
Is vaginal washing associated with increased risk of HIV-1 acquisition? | Q56918951 | ||
HIV Incidence Among Women of Reproductive Age in Malawi and Zimbabwe | Q57207552 | ||
Bacterial vaginosis and disturbances of vaginal flora | Q57207589 | ||
An Intervention to Reduce Vaginal Douching Among Adolescent and Young Adult Women: A Randomized, Controlled Trial | Q57555470 | ||
Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers | Q57608799 | ||
Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV | Q62490215 | ||
Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women | Q43871188 | ||
The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania | Q43945952 | ||
Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study | Q45132452 | ||
Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women | Q45420335 | ||
Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study | Q46865501 | ||
Family planning methods among women in a vaginal microbicide feasibility study in rural KwaZulu-Natal, South Africa. | Q47424651 | ||
Candida infection as a risk factor for HIV transmission | Q47752381 | ||
The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study | Q30229296 | ||
A cross cultural study of vaginal practices and sexuality: implications for sexual health | Q30882165 | ||
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
South Africa's experience of the closure of the cellulose sulphate microbicide trial | Q33293586 | ||
Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis | Q33531770 | ||
Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa? | Q33586189 | ||
Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial | Q33833895 | ||
Use of injectable progestin contraception and risk of STI among South African women | Q33988276 | ||
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations | Q34055986 | ||
Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials | Q34152713 | ||
Hormonal contraception and the risk of HIV acquisition | Q34588016 | ||
Inhibiting sexual transmission of HIV-1 infection | Q35709090 | ||
Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms | Q36323261 | ||
Preclinical evaluation of lime juice as a topical microbicide candidate | Q36485068 | ||
Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis | Q36501112 | ||
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial | Q36740882 | ||
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis | Q36953574 | ||
Vaginal practices, microbicides and HIV: what do we need to know? | Q37006169 | ||
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania | Q37098217 | ||
Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies | Q37136326 | ||
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies | Q37211585 | ||
Microbicides and HIV prevention: lessons from the past, looking to the future | Q37633913 | ||
Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. | Q37855033 | ||
Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania | Q37862938 | ||
Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial | Q37867045 | ||
Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. | Q38876194 | ||
Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia | Q39068509 | ||
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort | Q39140442 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human immunodeficiency virus infectious disease | Q18556697 |
Retroviridae infectious disease | Q19000689 | ||
bacterial vaginosis | Q804521 | ||
meta-analysis | Q815382 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | e1000416 | |
P577 | publication date | 2011-02-15 | |
P1433 | published in | PLOS MEDICINE | Q1686921 |
P1476 | title | Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis | |
P478 | volume | 8 |
Q52320573 | 'You'll always stay right': understanding vaginal products and the motivations for use among adolescent and young women in rural KZN. |
Q35589775 | A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean |
Q35904763 | A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors |
Q36358897 | A Perspective on Progress and Gaps in HIV Prevention Science |
Q30849067 | A bio-behavioral intervention to decrease intravaginal practices and bacterial vaginosis among HIV infected Zambian women, a randomized pilot study |
Q36302805 | A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health |
Q41697082 | A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa |
Q92173160 | A novel nested polymerase chain reaction targeting the testis-specific protein Y-encoded family of genes for high sensitivity of recent semen exposure detection: Comparison with four other assays of semen detection |
Q37682945 | Addressing intravaginal practices in women with HIV and at-risk for HIV infection, a mixed methods pilot study |
Q35131236 | Adolescent girls and young women: key populations for HIV epidemic control |
Q36899773 | Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States |
Q36487808 | Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda |
Q37310306 | An Intervention to Decrease Intravaginal Practices in HIV-Infected Women in Zambia: A Pilot Study |
Q34399672 | An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women |
Q55562325 | Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid. |
Q61810656 | Association between vaginal washing and vaginal bacterial concentrations |
Q35989741 | Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study |
Q36665412 | Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment |
Q47731889 | Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition |
Q37693958 | Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation |
Q40562427 | Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. |
Q41684764 | Cessation of intravaginal practices to prevent bacterial vaginosis: a pilot intervention in Zimbabwean women |
Q58088897 | Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility |
Q37907303 | Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide |
Q35134408 | Comparing local perspectives on women's health with statistics on maternal mortality: an ethnobotanical study in Bénin and Gabon |
Q27027323 | Contraceptive methods and risk of HIV acquisition or female-to-male transmission |
Q35128707 | Correlates of the molecular vaginal microbiota composition of African women |
Q58449581 | Determinants of Vaginal Cleansing, Application, and Insertion in Tete Province, Mozambique, and Products Used |
Q56836368 | Diagnostics as Prevention - A Rapid Testing-Based Strategy of Sex Workers against Sexual HIV Exposure |
Q40332034 | Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology. |
Q93054589 | Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota |
Q39196157 | Douching practices among female sex workers in Phnom Penh, Cambodia |
Q36497840 | Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples |
Q89120624 | Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis |
Q92180009 | Effects of an over-the-counter lactic-acid containing intra-vaginal douching product on the vaginal microbiota |
Q38667599 | Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study |
Q50066790 | Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study. |
Q56930898 | Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women |
Q37628546 | Examining targets for HIV prevention: intravaginal practices in Urban Lusaka, Zambia |
Q30387557 | Factors Driving the HIV Epidemic in Southern Africa |
Q47108119 | From menarche to menopause: A population-based assessment of water, sanitation, and hygiene risk factors for reproductive tract infection symptoms over life stages in rural girls and women in India |
Q38060213 | Genital immunology and HIV susceptibility in young women |
Q38656224 | Genital inflammation, immune activation and risk of sexual HIV acquisition. |
Q46119171 | HIV and adolescents: focus on young key populations |
Q31130557 | HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses |
Q40431590 | High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study |
Q34038050 | High level of soluble HLA-G in the female genital tract of Beninese commercial sex workers is associated with HIV-1 infection |
Q21144588 | Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis |
Q98158318 | Host Genetic Factors Associated with Vaginal Microbiome Composition in Kenyan Women |
Q35905458 | Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection |
Q91673318 | Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa |
Q58554986 | Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility |
Q30831315 | Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study |
Q55328542 | Incidence of sexually transmitted infections during pregnancy. |
Q40805771 | Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells |
Q38422546 | Inflammation and HIV Transmission in Sub-Saharan Africa |
Q40099236 | Influencing the importance of health, partners, and hygiene among Zambian women |
Q43535288 | Intermediate vaginal flora and bacterial vaginosis are associated with the same factors: findings from an exploratory analysis among female sex workers in Africa and India |
Q47713837 | Intermediate vaginal flora is associated with HIV prevalence as strongly as bacterial vaginosis in a cross-sectional study of participants screened for a randomised controlled trial |
Q35542152 | Interventions to prevent sexually transmitted infections, including HIV infection |
Q40456116 | Intravaginal Practices and Prevalence of Sexual and Reproductive Tract Infections Among Women in Rural Malawi. |
Q34651213 | Intravaginal Practices and Risk of Bacterial Vaginosis and Candidiasis Infection Among a Cohort of Women in the United States |
Q36767695 | Intravaginal Practices in Female Sex Workers in Cambodia: A Qualitative Study |
Q35669115 | Intravaginal cleansing among women attending a sexually transmitted infection clinic in Kingston, Jamaica |
Q36828511 | Intravaginal practices among HIV-negative female sex workers along the US-Mexico border and their implications for emerging HIV prevention interventions |
Q40138646 | Intravaginal practices among young HIV-infected women in Lusaka, Zambia |
Q90282690 | Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia |
Q35652018 | Intravaginal practices and lactobacilli colonization among women in Accra, Ghana |
Q21199583 | Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting |
Q38806789 | Intravaginal practices are associated with greater odds of high-risk HPV infection in Haitian women |
Q21129223 | Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health |
Q39021401 | Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women |
Q35077640 | Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process |
Q90181768 | Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice |
Q38062882 | Methodological lessons from clinical trials and the future of microbicide research |
Q35953765 | Motivations for Intravaginal Product Use among a Cohort of Women in Los Angeles |
Q36409225 | Oral antiretroviral chemoprophylaxis: current status |
Q38849530 | Penile Anaerobic Dysbiosis as a Risk Factor for HIV Infection |
Q58449588 | Prevalence and Motivations of Vaginal Practices in Tete Province, Mozambique |
Q34061684 | Prevalence of human papillomavirus in adolescent girls before reported sexual debut |
Q53701932 | Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site. |
Q52683139 | Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies |
Q46904065 | Preventing HIV in U.S. Women and Girls: A Call for Social Action |
Q62899244 | Results from a cross-sectional sexual and reproductive health study among school girls in Tanzania: high prevalence of bacterial vaginosis |
Q89633246 | Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis |
Q40458451 | Sexual Behavior and Vaginal Practices During Pregnancy and Postpartum: Implications for HIV Prevention Strategies. |
Q39417107 | Sexual Risk and Intravaginal Practice Behavior Changes During Pregnancy |
Q37061624 | Systemic and Topical Drugs for the Prevention of HIV Infection: Antiretroviral Pre-exposure Prophylaxis |
Q64085416 | The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission |
Q97525299 | The Vaginal Microbiota Among Adolescent Girls in Tanzania Around the Time of Sexual Debut |
Q33898250 | The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands |
Q40047225 | The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field |
Q27692596 | The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. |
Q95661202 | The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility |
Q37526198 | The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa |
Q59808471 | The murine vaginal microbiota and its perturbation by the human pathogen group B Streptococcus |
Q43698611 | The practice of puxa-puxa among Mozambican women: a systematic inventory of motives. |
Q58697026 | The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women |
Q35154469 | The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women |
Q35641764 | Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women |
Q33767641 | Understanding intra-vaginal and labia minora elongation practices among women heads-of-households in Zambézia Province, Mozambique |
Q37691102 | Understanding motives for intravaginal practices amongst Tanzanian and Ugandan women at high risk of HIV infection: the embodiment of social and cultural norms and well-being |
Q35952664 | Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis |
Q36570431 | Use of barrier protection for sexual activity among women who have sex with women |
Q37120040 | Vaginal Cleansing Practices in HIV Infected Zambian Women |
Q36301992 | Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. |
Q64897572 | Vaginal Microbiota Composition Correlates Between Pap Smear Microscopy and Next Generation Sequencing and Associates to Socioeconomic Status. |
Q37843990 | Vaginal douching and sexually transmitted infections among female sex workers: a cross-sectional study in three provinces in China |
Q40124611 | Vaginal dysbiosis and pre-exposure prophylaxis efficacy |
Q64967515 | Vaginal herb use and Chlamydia trachomatis infection: cross-sectional study among women of various ethnic groups in Suriname. |
Q50101300 | Vaginal microbiota and susceptibility to HIV. |
Q101403240 | Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women |
Q34650730 | Vaginal practices among women at high risk of HIV infection in Uganda and Tanzania: recorded behaviour from a daily pictorial diary |
Q91908877 | Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa |
Q57169396 | Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention |
Q41610297 | Zambian Women in South Africa: Insights Into Health Experiences of Labia Elongation |
Search more.